Ellen Jessouroun

Title: Innovations of Ellen Jessouroun in Vaccine Development

Introduction

Ellen Jessouroun is a notable inventor based in Rio de Janeiro, Brazil. She has made significant contributions to the field of vaccine development, particularly through her innovative work on polysaccharide-protein conjugate vaccines. Her research has the potential to enhance vaccine efficacy and production efficiency.

Latest Patents

Ellen Jessouroun holds a patent for a process that prepares polysaccharide-protein conjugate vaccines. This patent outlines methods for manufacturing these vaccines at high yield. The innovative approach involves the reaction of a hydrazide group on one reactant with an aldehyde group on another reactant. This reaction occurs rapidly and achieves high conjugation efficiency. Additionally, the patent describes simplified purification processes to separate the conjugate product from unconjugated proteins, polysaccharides, and other small molecule by-products.

Career Highlights

Throughout her career, Ellen has worked with esteemed organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and Fiocruz. Her work has been instrumental in advancing vaccine technology and public health initiatives.

Collaborations

Ellen has collaborated with several professionals in her field, including Ivna Alana Freitas Brasileiro Da Silveira and Renata Chagas Bastos. These collaborations have contributed to her research and the successful development of her patented processes.

Conclusion

Ellen Jessouroun's innovative work in vaccine development exemplifies the impact of scientific research on public health. Her contributions through her patent and collaborations highlight the importance of innovation in addressing global health challenges.